Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases

BACKGROUND: With acute myeloid leukemia (AML), there are limited data about the accuracy of day 14 bone marrow (BM) biopsies for predicting complete remission as compared to day 28 BM biopsy results. We here aimed to estimate the correlation between, and the diagnostic accuracy of, both approaches....

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaleh, Khalid, Aleem, Aamer, Almomen, Abdulkareem, Anjum, Farhan, Alotaibi, Ghazi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980929/
https://www.ncbi.nlm.nih.gov/pubmed/29479992
http://dx.doi.org/10.22034/APJCP.2018.19.2.421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980929/
https://www.ncbi.nlm.nih.gov/pubmed/29479992
http://dx.doi.org/10.22034/APJCP.2018.19.2.421

Ejemplares similares